SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Saeki, Y
Right arrow Articles by Suemura, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saeki, Y
Right arrow Articles by Suemura, M
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Maintaining remission of lupus erythematosus profundus (LEP) with cyclosporin A

Y Saeki

Department of Molecular Medicine, Osaka University Medical School, 2-2 Yamada-Oka, Suita City, Osaka 565-0871, Japan Tel: (+ 81) 6 6879 3831; Fax: (+ 81) 6 6879 3839 saekiy{at}imed3.med.osaka-u.ac.jp

S Ohshima

Department of Molecular, Medicine Osaka University Medical School, Suita City, Osaka, Japan

I Kurimoto

H Miura

Department of Dermatology, Osaka University Medical School, Suita City, Osaka, Japan

M Suemura

Department of Molecular, Medicine Osaka University Medical School, Suita City, Osaka, Japan

We report a young female patient with recurrent lupus erythematosus profundus (LEP) who has successfully maintained remission of LEP with cyclosporin A (CsA), although conventional treatments such as systemic corticosteroids (low-dose), dapsone, and other immunosuppressive drugs (azathiopurine, cyclophosphamide) could not maintain remission.

Key Words: LEP • SLE • cyclosporin A

Lupus, Vol. 9, No. 5, 390-392 (2000)
DOI: 10.1191/096120300678828406
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
M Ishii, Y Muramoto, H Kosaka, S Ohshima, T Mima, Y Katada, S Hirohata, and Y Saeki
A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis)
Lupus, January 1, 2007; 16(1): 67 - 69.
[PDF]


Advertisement